BamSEC and AlphaSense Join Forces
Learn More

Elite Pharmaceuticals, Inc.

OTC: ELTP    
Share price (12/23/24): $0.55    
Market cap (12/23/24): $588 million
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.1
from 8-K 3 pages Amendment to the Articles of Incorporation of Elite Pharmaceuticals, Inc.
12/34/56
EX-3.2
from 8-K 12 pages Amended and Restated Bylaws of Elite Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 3 pages Elite Pharmaceuticals, Inc. Nvid: Nv20121008448
12/34/56
EX-3.1
from 8-K 11 pages Certificate of Designation of Series J Convertible Preferred Stock of Elite Pharmaceuticals, Inc.,
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment to Articles of Incorporation for Nevada Profit Corporations
12/34/56
EX-3.1
from 8-K 16 pages Amended and Restated Bylaws of Elite Pharmaceuticals, Inc
12/34/56
EX-3.2
from 8-K 12 pages Bylaws of Elite Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 53 pages Articles of Incorporation of Elite Pharmaceuticals, Inc
12/34/56
EX-3.2
from 8-K 3 pages Certificate of Correction Relating to the Amended Certificate of Designation of the Series C 8% Convertible Preferred Stock of Elite Pharmaceuticals, Inc. Filed in the Office of the Secretary of State of the State of Delaware on August 12, 2011
12/34/56
EX-3.1
from 8-K 3 pages Certificate of Correction Relating to the Amended Certificate of Designation of the Series B 8% Convertible Preferred Stock of Elite Pharmaceuticals, Inc. Filed in the Office of the Secretary of State of the State of Delaware on August 12, 2011
12/34/56
EX-3.2
from 8-K 20 pages Amended Certificate of Designations of the Series C 8 % Convertible Preferred Stock of Elite Pharmaceuticals, Inc. Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.1
from 8-K 23 pages Amended Certificate of Designations of the Series B 8 % Convertible Preferred Stock of Elite Pharmaceuticals, Inc. Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.2
from 8-K 24 pages Amended Certificate of Designations of the Series E Convertible Preferred Stock of Elite Pharmaceuticals, Inc. Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.1
from 8-K 34 pages Amended Certificate of Designations of the Series D 8 % Convertible Preferred Stock of Elite Pharmaceuticals, Inc. Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.1
from 8-K 22 pages Elite Pharmaceuticals, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series E Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law Terms of Series E Convertible Preferred Stock
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment of Certificate of Incorporation of Elite Pharmaceuticals, Inc
12/34/56
EX-3.3
from 8-K ~50 pages Articles of Incorporation or Bylaws
12/34/56
EX-3.2
from 8-K ~50 pages Articles of Incorporation or Bylaws
12/34/56
EX-3.1
from 8-K ~50 pages Articles of Incorporation or Bylaws
12/34/56
EX-3.01
from 8-K 3 pages State of Delaware Secretary of State Division of Corporations Delivered 03:21 Pm 06/26/2008 Filed 03:09 Pm 06/26/2008 Srv 080734267 - 2791326 File Certificate of Amendment of Certificate of Incorporation of Elite Pharmaceuticals, Inc
12/34/56